Stockscreener 앱 받기
4.37
8.58%
-0.41
Entrada Therapeutics Inc 주식(TRDA)의 최신 뉴스
TRDA 8-K & SEC Filings - Yahoo! Finance Canada
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45 - GlobeNewswire Inc.
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study - GlobeNewswire Inc.
Entrada Therapeutics: Weak Dystrophin Data May Be Creating A Buying Opportunity - Seeking Alpha
Coya Therapeutics, Inc. (COYA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Coya Therapeutics, Inc. (COYA) stock price, news, quote and history - Yahoo Finance Singapore
TRDA S-8 & SEC Filings - Yahoo! Finance Canada
Responsive Playbooks and the TRDA Inflection - Stock Traders Daily
MPM BioVentures 2014, L.P. Offloads 259,837 Shares of Entrada Therapeutics (NASDAQ: TRDA) at $7.11-$7.41 Each - Kalkine Media
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com Australia
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program - The Manila Times
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com Nigeria
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com Australia
Entrada therapeutics 10% owner MPM BioVentures sells $1.9M stock - Investing.com
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares - Investing.com
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com India
Entrada therapeutics 10% owner MPM BioVentures sells $1.9M stock By Investing.com - Investing.com Canada
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com Canada
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com UK
MPM funds sell Entrada (TRDA) shares, still hold stakes over 1.7M each - Stock Titan
MPM funds sell 259,837 Entrada Therapeutics (TRDA) shares over 3 days - Stock Titan
Entrada Therapeutics at cantorfitzgerald healthcare conference: data catalysts ahead By Investing.com - Investing.com South Africa
Entrada Therapeutics at cantorfitzgerald healthcare conference: data catalysts ahead By Investing.com - Investing.com India
Entrada Therapeutics at cantorfitzgerald healthcare conference: data catalysts ahead By Investing.com - Investing.com Canada
Mpm Bioventures 2018 sells $1.9m in Entrada Therapeutics shares By Investing.com - Investing.com South Africa
MPM BIOVENTURES 2018, L.P. Disposes 86,482 Shares of Entrada Therapeutics Between September 1-3, 2026 - Kalkine Media
Entrada Therapeutics' R&D President Sethuraman Natarajan Forfeits 2,079 Shares at $7.14 Each on September 2, 2026 - Kalkine Media
Entrada Therapeutics CFO Wentworth Kory James Forfeits 1,733 Shares at $7.14 Each (NASDAQ: TRDA) - Kalkine Media
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics By Investing.com - Investing.com South Africa
TRDAEntrada Therapeutics Inc Revenue Breakdown - Finviz
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics By Investing.com - Investing.com Nigeria
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares By Investing.com - Investing.com Canada
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics By Investing.com - Investing.com India
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics By Investing.com - Investing.com Canada
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares By Investing.com - Investing.com Nigeria
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares By Investing.com - Investing.com Australia
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics - Investing.com
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares By Investing.com - Investing.com UK
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics By Investing.com - Investing.com UK
Institutional holder sells Entrada (NASDAQ: TRDA) shares over three days - Stock Titan
MPM funds sell Entrada (TRDA) shares without 10b5-1 plan - Stock Titan
Entrada Therapeutics (TRDA) CEO sale is tax-driven, still owns 517,290 shares - Stock Titan
Automatic tax sale trims Entrada Therapeutics (TRDA) CFO stake - Stock Titan
Automatic tax sale trims Entrada Therapeutics (TRDA) insider stake - Stock Titan
Automatic tax sale trims Entrada Therapeutics (TRDA) COO holdings - Stock Titan
Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares - Investing.com
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Liquidity Mapping Around (TRDA) Price Events - news.stocktradersdaily.com
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
4.22%
자본화:
|
볼륨(24시간):